Your Incision Should Be Your Decision™
AFib surgery second opinion
A cardiac surgeon and cardiologist independently review your complete record—then organize how AFib pattern, prior treatment, other heart disease, stroke prevention, surgical risk, and your priorities shape the options worth discussing.
No referral or travel required. With your authorization, the records team can help obtain what is needed.
Your rhythm history.
The question is not simply “Maze or catheter ablation?” It is “which options fit this rhythm history, this heart, and this moment?”
Explore a sample reportAFib, in context
AFib care can involve symptom control, rhythm control, stroke prevention, risk-factor treatment, procedures, or surveillance. The plan depends on the pattern and burden of AFib, prior treatment, the rest of the heart, other health conditions, and the reason a procedure is being considered now. Continue following your treating team’s instructions while seeking clarification.
Paroxysmal, persistent, long-standing persistent, and permanent AFib are not interchangeable labels. Rhythm history, monitoring, duration, symptom burden, and prior cardioversions help define the decision in front of you.
Rate-control and rhythm-control medicines, anticoagulation, cardioversion, prior catheter ablation, risk-factor treatment, and the response to each can change which options remain reasonable to discuss.
When valve surgery, bypass, or another cardiac operation is already being considered, surgical ablation and left-atrial-appendage management may belong in the same conversation. That is different from choosing a standalone procedure.
Atrial size, ventricular function, valve disease, coronary disease, heart failure, sleep apnea, kidney or lung disease, frailty, and stroke and bleeding risk can alter timing, candidacy, and center fit.
Maze, catheter, appendage—or no procedure now
The purpose of a second opinion is not to favor an incision, catheter, device, or medicine. It is to make the goal, candidacy, trade-offs, unanswered questions, and limits of each clinically relevant path visible.
Catheter ablation may be considered for selected patients when rhythm control is the goal. AFib pattern, symptoms, heart function, atrial anatomy, prior medicines, previous ablation, and procedural goals all affect the discussion. A less invasive procedure is not automatically the right procedure for every record.
A Cox-Maze or other surgical-ablation strategy may be discussed during another heart operation or, in selected circumstances, as a standalone or hybrid approach. The lesion set, left-atrial-appendage plan, prior treatment, anatomy, operative risk, and the team’s experience all matter.
Anticoagulation, percutaneous left-atrial-appendage occlusion, and surgical appendage management address stroke risk; they do not by themselves treat the abnormal rhythm. Device labeling, anatomy, bleeding history, other planned procedures, and the treating team’s judgment shape candidacy.
Rate control, rhythm-control medication, anticoagulation when indicated, risk-factor treatment, cardioversion, or continued monitoring may remain reasonable depending on symptoms, AFib burden, comorbidities, prior treatment, and preferences. A procedure is not the only possible next step.
The reasonable discussion may include more than one step, a staged approach, or no invasive procedure now. This service does not diagnose, prescribe, or change medication.
The whole-decision view
A useful review separates the goal of rhythm treatment from the goal of stroke prevention, distinguishes catheter and surgical questions, and shows where missing evidence or specialty input still matters.
Duration, burden, symptoms, monitoring method, and whether normal rhythm has been restored before all affect how the record should be interpreted.
Restoring rhythm does not automatically remove the need to reassess stroke prevention. Anticoagulation and appendage-management questions should be made explicit.
If the chest is already being opened for valve or coronary surgery, the incremental discussion is different from choosing standalone surgery solely for AFib.
Recurrence after catheter ablation may lead to repeat catheter treatment, surgical or hybrid evaluation, medicine, cardioversion, or monitoring. The full context matters.
When open-heart surgery is relevant, STS PROM, EuroSCORE II, and AATS can help frame operative risk. They are not presented as risk calculators for catheter ablation.
A center’s rhythm-surgery program, lesion-set experience, multidisciplinary coordination, outcomes, and ability to manage the rest of the heart may matter when surgery is being considered.
WHITEGLOVE Heart Team
Every service level includes both independent reviews and both physician signatures. The reviewing physicians confer before the report is finalized. Your treating electrophysiology team remains essential when catheter ablation or device therapy is being considered.
Concomitant versus standalone surgery, lesion set, appendage management, other cardiac disease, operative risk, recovery, and procedure-specific center experience.
WHITEGLOVE Insights™Independent reads.AFib pattern and burden, symptoms, ventricular and valve context, prior treatment, anticoagulation and stroke-risk history, and questions for the treating electrophysiology team.
WHITEGLOVE Insights™
The report is written for patients and families, but grounded in the complete source record, current evidence, and two physician reviews.
Download a sample reportRhythm pattern, documented burden, symptoms, cardioversions, medicines, prior ablation, and the proposed plan—clearly tied to the source record.
Catheter ablation, surgical or hybrid ablation, medical and rhythm management, cardioversion, monitoring, and left-atrial-appendage options only when clinically relevant.
The available stroke-risk and bleeding-risk information, anticoagulation history, appendage anatomy when documented, and the limits of the record.
When open-heart surgery is relevant, STS PROM, EuroSCORE II, and AATS considered separately, with available inputs, missing data, and model limitations visible.
Patient-facing explanations connect your rhythm history, echocardiography, monitoring, prior procedures, comorbidities, and goals to the decision being discussed.
A practical check for unresolved rhythm documentation, imaging, testing, medication history, or clinical context to discuss with the treating team.
When relevant, the report identifies questions about procedure-specific experience, multidisciplinary coordination, geography, and practical fit to bring to the clinicians responsible for your care.
A concise set of questions and next steps to bring to the electrophysiology, cardiology, and surgical physicians responsible for your care.
What may still be missing
A missing study or record does not automatically mean care was inadequate. It means the limits of the available review should be visible—and turned into useful questions for the treating team.
ECGs, ambulatory monitoring, device data when available, AFib duration and burden, symptom correlation, cardioversion history, and what “recurrence” means in this record.
Atrial size, ventricular function, valve disease, pulmonary pressure, and other findings that may affect rhythm strategy or a combined operation.
Antiarrhythmic and rate-control medicines, anticoagulation, prior catheter-ablation reports, operative reports, complications, response, and reasons treatment changed.
Relevant risk factors, prior stroke or bleeding, kidney and liver function, medication tolerance, and appendage imaging or device planning when applicable.
The clinical and laboratory variables needed for defensible cardiac-surgery risk estimates, plus the limits of every model.
Heart failure, sleep apnea, weight, blood pressure, alcohol exposure, thyroid disease, lung disease, frailty, goals, caregiving, and recovery constraints.
Evidence, with its limits visible
Guidelines describe populations and risk estimates describe modeled outcomes. Neither predicts an individual result or replaces clinical judgment. FDA labeling and patient-specific eligibility should be reviewed by the treating team.
How it works
The complete-record milestone matters: the 24-hour written-review clock starts only after the records and imaging required for your case have been received and confirmed.
Tell a Heart Team specialist what you were told and what feels unresolved. No referral or records are needed for the first conversation.
Upload what you have or authorize the records team to help gather rhythm studies, imaging, procedure reports, notes, labs, and the proposed plan.
A cardiac surgeon and cardiologist examine the same complete record from different clinical perspectives, then confer.
Your WHITEGLOVE Insights™ report is delivered within 24 hours after the records and imaging required for the review are complete.
Choose the support you want
Start with the written report. Add physician consultation or concierge access only if it fits your decision. Direct pay; no insurance claim is submitted.
Independent review by both physicians and the co-signed written report.
The written report plus a live consultation with one reviewing physician.
The written report plus both reviewing physicians together on the consultation.
The Heart Team consultation plus concierge access until the day of surgery.
AFib surgery second opinion FAQ
A second opinion may be useful when surgical Maze, catheter ablation, a hybrid approach, left-atrial-appendage management, another heart operation, or continued medical and rhythm management is being discussed and you want the reasoning organized around your complete record. It should not delay urgent or time-sensitive care directed by your treating team.
Catheter ablation is performed through blood vessels without an open-chest incision. Surgical ablation creates a planned lesion set on the atria and may be performed during another heart operation or, in selected cases, as a standalone or hybrid procedure. AFib pattern, symptoms, atrial and cardiac anatomy, prior treatment, other planned surgery, procedural risk, and patient goals help determine which approaches are reasonable to discuss.
It may belong in the discussion for some patients with AFib who are already undergoing cardiac surgery. The answer depends on the operation, AFib history, anatomy, rhythm goals, operative risk, left-atrial-appendage plan, and the treating team’s experience. The review explains whether the available record addresses those questions; it does not prescribe an additional procedure.
No. Percutaneous devices and surgical appendage management are intended to address stroke risk from the left atrial appendage; they do not treat the abnormal rhythm itself. Candidacy, anatomy, anticoagulation, bleeding history, device labeling, and whether another procedure is planned are separate parts of that decision.
Do not stop anticoagulation unless the clinician responsible for your care directs you to do so. Rhythm outcome, stroke risk, bleeding risk, the specific procedure or device, follow-up imaging, and other clinical factors may all affect the plan. The review can organize what your record says and identify questions for the treating team; it does not change prescriptions.
The exact record depends on the decision. It commonly includes ECGs and ambulatory-monitoring results, echocardiogram images and reports, prior ablation or operative reports, cardioversion history, medication and anticoagulation history, laboratory results, clinical notes, and imaging related to another planned heart operation. With your authorization, the records team can help identify, request, and organize what is needed.
A cardiac surgeon and cardiologist independently review the same complete record, then confer and co-sign one WHITEGLOVE Insights™ report. Those are the two WHITEGLOVE reviewers. Your treating electrophysiology team remains important when catheter ablation or device therapy is being considered.
The written report is delivered within 24 hours after the records and imaging required for your review have been received and confirmed complete. Time spent requesting, transferring, or collecting records is outside that 24-hour window.
After your complimentary conversation, we email the package we recommend, what it includes, and the secure next step. Every option includes two independent physician reviews and a co-signed written report. The service is direct pay and WHITEGLOVEMD does not submit an insurance claim.
No. WHITEGLOVEMD provides independent educational decision support and medical-record review. It does not diagnose, prescribe, perform procedures, provide emergency care, or replace the clinicians responsible for your treatment.
Do not delay urgent or time-sensitive treatment while waiting for WHITEGLOVEMD. If you may be experiencing a medical emergency, call 911 immediately.
The decision stays yours
Start with a complimentary orientation or begin the two-physician written review.